JNMT, which has been published since 1973, is a quarterly peer-reviewed publication that focuses on technology, quality assurance, radiation safety, expert perspectives and clinical applications of nuclear medicine and molecular imaging.

JNM and JNMT ahead-of-print articles will be available on the journals' Web sites (jnm.snmjournals.org; tech.snmjournals.org), hosted by HighWire Press.


About SNM-Advancing Molecular Imaging and Therapy
SNM is an international scientific and professional organization of more than 16,000 members dedicated to promoting the science, technology and practical applications of molecular and nuclear imaging to diagnose, manage and treat diseases in women, men and children. Founded more than 50 years ago, SNM continues to provide essential resources for health care practitioners and patients; publish the most prominent peer-reviewed journal in the field (the Journal of Nuclear Medicine); host the premier annual meeting for medical imaging; sponsor research grants, fellowships and awards; and train physicians, technologists, scientists, physicists, chemists and radiopharmacists in state-of-the-art imaging procedures and advances. SNM members have introduced-and continue to explore-biological and technological innovations in medicine that noninvasively investigate the molecular basis of diseases, benefiting countless generations of patients. SNM is based in Reston, Va.; additional information can be found online at http://www.snm.org.

Full Caption:
Initial clinical experiences are being reported with fused 3-dimensional SPECT/CT in patients with coronary artery disease. In addition to being intuitively convincing, the fusion images provide additional diagnostic information on the functional relevance of coronary artery lesions.
The Journal of Nuclear Medicine

Back to HCB News

More Industry Headlines